Drug details

Tiglutik (riluzole oral suspension)

type of Glutamate Inhibitors

Tiglutik (riluzole) is indicated for the treatment of amyotrophic lateral sclerosis (ALS).

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• loss of appetite,
• itching,
• yellowing of the skin or eyes (jaundice)
• fever,
• shortness of breath,
• tiredness,
• wheezing,
• sore throat,
• stomach pain (upper right side),
• mouth sores,
• dark urine, and
• skin sores,
• cough with mucus,
• dry cough,
• sudden chest pain,

The following drugs are related to Tiglutik, either as a replacement or used together:

• Radicava (edaravone injection)
• Radicava ORS (edaravone oral suspension)
• Qaslody (tofersen injection, for intrathecal use)
• Rilutek (riluzole)